Computer-Based Technologies for Virtual Screening and Analysis of Chemical Compounds Promising for Anti-HIV-1 Drug Design

被引:0
|
作者
Andrianov, A. M. [1 ]
Kashyn, I. A. [1 ,2 ]
Tuzikov, A. V. [2 ]
机构
[1] Inst Bioorgan Chem NASB, 5-2 Acad Kuprevich St, Minsk 220141, BELARUS
[2] United Inst Informat Problems NASB, 6 Surganov St, Minsk 220012, BELARUS
来源
PATTERN RECOGNITION AND INFORMATION PROCESSING | 2017年 / 673卷
关键词
Virtual screening; Molecular docking; Molecular dynamics; Binding free energy calculations; HIV-1 entry inhibitors; Broadly neutralizing antibodies; NEUTRALIZING ANTIBODIES; POTENT NEUTRALIZATION; HIV-1; DISCOVERY; BROAD; INHIBITORS; GP120;
D O I
10.1007/978-3-319-54220-1_2
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Computer-based technologies for in silico drug development comprising virtual screening, high-throughput docking, molecular dynamics simulations, and binding free energy calculations are presented. The efficiency of these technologies is demonstrated by the identification of novel potential anti-HIV-1 agents able to mimic pharmacophoric properties of potent and broad neutralizing antibodies 10e8, VRC01, and 3074 that target three different functionally conserved regions of the viral envelope proteins.
引用
收藏
页码:14 / 23
页数:10
相关论文
共 49 条
  • [41] Structure-based virtual screening and docking studies for the identification of novel inhibitors against wild and drug resistance strains of HIV-1 RT
    Subhash Chander
    Ashok Penta
    Sankaranarayanan Murugesan
    Medicinal Chemistry Research, 2015, 24 : 1869 - 1883
  • [42] A computer aided drug discovery based discovery of lead-like compounds against KDM5A for cancers using pharmacophore modeling and high-throughput virtual screening
    Tariq, Asma
    Rehman, Hafiz Muzzammel
    Mateen, Rana Muhammad
    Ali, Moazzam
    Mutahir, Zeeshan
    Afzal, Muhammad Sohail
    Sajjad, Muhammad
    Gul, Roquyya
    Saleem, Mahjabeen
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2022, 90 (03) : 645 - 657
  • [43] Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp
    Murali, Mahadevamurthy
    Gowtham, Hittanahallikoppal Gajendramurthy
    Ansari, Mohammad Azam
    Alomary, Mohammad N.
    Alghamdi, Saad
    Almehmadi, Mazen
    Singh, Sudarshana Brijesh
    Shilpa, Natarajamurthy
    Aiyaz, Mohammed
    Kalegowda, Nataraj
    Ledesma, Ana E.
    Amruthesh, Kestur Nagaraj
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (12) : 969 - 980
  • [44] Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation
    Sabki, Abdellah
    Khelifi, Lakhdar
    Kameli, Abdelkrim
    Baali, Salim
    CHEMISTRY & BIODIVERSITY, 2023, 20 (03)
  • [45] Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis
    Zaki, Magdi E. A.
    Al-Hussain, Sami A.
    Masand, Vijay H.
    Akasapu, Siddhartha
    Bajaj, Sumit O.
    El-Sayed, Nahed N. E.
    Ghosh, Arabinda
    Lewaa, Israa
    PHARMACEUTICALS, 2021, 14 (04)
  • [46] Identification of Sirtuin 1-targeted anti-Alzheimer agents using structure-based drug design and multi-database screening
    Chandola, Preeti
    Jain, Smita
    Singh, Ritu
    Jamali, Mohammad Chand
    Dwivedi, Jaya
    Sharma, Swapnil
    INDIAN JOURNAL OF CHEMISTRY, 2024, 63 (12): : 1240 - 1249
  • [47] Computational Model of the HIV-1 Subtype A V3 Loop: Study on the Conformational Mobility for Structure-Based Anti-AIDS Drug Design
    Andrianov, Alexander M.
    Anishchenko, Ivan V.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2009, 27 (02) : 179 - 193
  • [48] Allosteric covalent inhibition of TOE1 as potential unexplored anti-cancer target: structure-based virtual screening and covalent molecular dynamics analysis
    Kehinde, Ibrahim Oluwatobi
    Oduro-Kwateng, Ernest
    Soliman, Mahmoud E. S.
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2024, 44 (03) : 97 - 106
  • [49] QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds
    Hadiza Abdulrahman Lawal
    Adamu Uzairu
    Sani Uba
    Bulletin of the National Research Centre, 45 (1)